← Leaderboards
Carlos J Orihuela
University Of Alabama At Birmingham
$11,918,098
Attributed
$13,798,498
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,798,498 · 12
By mechanism
R01$11,162,154 · 5
R21$2,636,344 · 7
Top collaborators
- Hind Lal2 shared
- Elaine Tuomanen2 shared
- Herve S Tettelin1 shared
- Min Xie1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- David E Briles$11,417,266
- Champion Christdoss Selvakumar Deivanayagam$3,873,296
- Mark J Jedrzejas$768,237
- Jocelyn R Hauser$89,448
- Susan K. Hollingshead$2,112,996
Others in their field
Top investigators on “Streptococcus Pneumoniae”
- Jeffrey N. Weiser · New York University School Of Medicine$20,590,649
- Dallas Hughes · Novobiotic Pharmaceuticals, Llc$15,114,161
- Elaine Tuomanen · University Of Alabama At Birmingham$13,568,473
- Liise-Anne Pirofski · Yeshiva University$13,441,639
- Joseph P Mizgerd · Boston University Medical Campus$12,549,527
- Myron Max Levine · University Of Maryland Baltimore$12,500,000
Research focus
Streptococcus PneumoniaeCellsPneumoniaPneumococcal InfectionsHeartIn VitroVirulenceIn VivoMediatingCessation Of LifePathogenBacteriaInfectionEventLearningStreptococcus Pneumoniae Ply ProteinMutantLungToxinBlood CirculationMolecularCardiacProductionCell Death
Grant awards (40)
Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease$645,107
R01 · FY2025 · HL
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection$622,109
R01 · FY2025 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$547,115
R01 · FY2025 · AI · contact PI
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection$644,990
R01 · FY2024 · AI · contact PI
Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease$644,365
R01 · FY2024 · HL
Cardiac microlesion formation during invasive pneumococcal disease$437,177
R01 · FY2024 · AI · contact PI
PspA binds necroptotic cells to cause disease and transmit$411,647
R01 · FY2024 · AI · contact PI
Cardiomyocyte self-defense against Streptococcus pneumoniae$216,857
R21 · FY2024 · AI · contact PI
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection$657,115
R01 · FY2023 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$444,846
R01 · FY2023 · AI · contact PI
PspA binds necroptotic cells to cause disease and transmit$410,162
R01 · FY2023 · AI · contact PI
Cardiomyocyte self-defense against Streptococcus pneumoniae$179,732
R21 · FY2023 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$437,199
R01 · FY2022 · AI · contact PI
PspA binds necroptotic cells to cause disease and transmit$407,723
R01 · FY2022 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$442,403
R01 · FY2021 · AI · contact PI
PspA binds necroptotic cells to cause disease and transmit$411,793
R01 · FY2021 · AI · contact PI
Capsule protects intracellular pneumococci during vascular endothelial cell translocation$222,750
R21 · FY2021 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$455,461
R01 · FY2020 · AI · contact PI
PspA binds necroptotic cells to cause disease and transmit$407,836
R01 · FY2020 · AI · contact PI
Pneumococcal biofilm formation is SpxB dependent$188,543
R21 · FY2020 · AI · contact PI
Capsule protects intracellular pneumococci during vascular endothelial cell translocation$185,625
R21 · FY2020 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$361,860
R01 · FY2019 · AI · contact PI
Pneumococcal biofilm formation is SpxB dependent$238,563
R21 · FY2019 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$361,860
R01 · FY2018 · AI · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$364,297
R01 · FY2017 · AI · contact PI
Inhibition of necroptosis during inflamm-aging and pneumonia$220,500
R21 · FY2017 · AG · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$379,130
R01 · FY2016 · AI · contact PI
Inhibition of necroptosis during inflamm-aging and pneumonia$183,750
R21 · FY2016 · AG · contact PI
Cardiac microlesion formation during invasive pneumococcal disease$383,582
R01 · FY2015 · AI · contact PI
Mechanism of PsrP mediated adhesion$239,422
R01 · FY2013 · AI · contact PI
Mechanism of PsrP mediated adhesion$254,704
R01 · FY2012 · AI · contact PI
Statins protect against adverse cardiac events during pneumonia$186,042
R21 · FY2012 · HL · contact PI
Mechanism of PsrP mediated adhesion$254,704
R01 · FY2011 · AI · contact PI
Statins protect against adverse cardiac events during pneumonia$185,625
R21 · FY2011 · HL · contact PI
Mechanism of PsrP mediated adhesion$257,276
R01 · FY2010 · AI · contact PI
Age-associated Toll-like receptor dysfunction in the lungs$150,690
R21 · FY2010 · AG · contact PI
Mechanism of PsrP mediated adhesion$278,271
R01 · FY2009 · AI · contact PI
Age-associated Toll-like receptor dysfunction in the lungs$170,519
R21 · FY2009 · AG · contact PI
Age-associated inflammation increases susceptibility to pneumococcal infection$152,023
R21 · FY2008 · AG · contact PI
Age-associated inflammation increases susceptibility to pneumococcal infection$155,125
R21 · FY2007 · AG · contact PI